Disease Targets Services
-
Manufactured by MODAG GmbHbased in GERMANY
Certain proteins including α-synuclein can form disease-specific fibrillar amyloid aggregates. The misfolding/ aggregation pathway resulting in amyloid fibrils involves characteristic oligomer species which have been shown to be the most relevant toxic protein species. These pathological oligomers exhibit structural ...
-
Manufactured by ImmunoPrecise Antibodies Ltd.based in CANADA
Our hybrid of intelligence and technology platforms provide a distinctive end-to-end service model, designed to reduce time and risk with custom applications. We support our business partners in the quest to discover and develop novel antibodies against a broad range of classes of disease targets in “one-stop”, with:? An ...
-
by Amgen Inc.based in USA
and validate human disease ...
-
Manufactured by Creative Biogene-Mitochondrial Researchbased in USA
To further meet the needs of multi-group joint analysis, through the integrated analysis of multi-group data, Creative Biogene provides a systematic and overall solution for global researchers, such as mitochondrial regulation mechanism, disease target screening, biomarker discovery, and so on. We provide new ideas for researchers ...
-
Manufactured by Inovotion Sasbased in FRANCE
Target validation is an essential and critical phase of the drug discovery process. This is a crucial step before starting to develop a treatment based on a targeted protein that has been identified to play a role in the disease. The target protein’s role must be clearly identified before starting to develop a drug ...
-
Manufactured by BOC Sciencesbased in USA
Superparamagnetic iron oxide microbeads have broad applications in biomedicine, such as magnetic cell isolation and biomolecules purification, magnetic resonance imaging of diseased tissues, magnetic immunoassay, targeted delivery of drugs and antigens, hyperthermia aided chemo/radiotherapy, and so on. BOC Sciences offers ...
-
by Genmab A/Sbased in DENMARK
treatments. Our research and innovation teams consist of a strong antibody discovery engine connecting our antibody platform technologies with our target and disease biology knowledge. This synergy is the lifeblood of our R&D organization, where our creations enter clinical ...
-
Manufactured by Synbio Technologies LLCbased in USA
The immune system is a very robust “antibody factory” that consistently produces antibodies to fight infections and diseases by recognizing and targeting infected cells or pathogens (antigens). The emergence of single B cell antibody technology has enabled a new strategy for discovery of naturally occurring antibody drugs. The single ...
-
Manufactured by Deep Genomicsbased in CANADA
AI Drives Unprecedented Number of Valuable Medicines by Combining Prediction and Scale. Our proprietary AI Workbench is designed for data-driven prediction, positive feedback loops, and exponential growth. It enables us to identify leads for over 50% of the novel targets we select, and to do so quickly. This is a game changer. In 2018, ...
-
Manufactured by Kymab, a Sanofi companybased in UNITED KINGDOM
by working on common pathways that are frequently used in this area, often with varying tissue specificity or multiple functionality depending on the disease and the tissue distribution. Our antibody-based drug molecules can provide exquisite specificity for those targets even in situations where the sequence homology between mouse and human is ...
-
Manufactured by CENTOGENE N.V.based in GERMANY
We provide a broad range of services to successfully operate clinical trials. We leverage our proprietary Bio/Databank, multiomic platform, extensive physician network and our experts to ensure efficient and effective solutions to drive progress in the rare disease ...
-
based in GERMANY
Act beyond human and experimental limitations. Knowledge to advance game-changing therapies from idea to market. The world's biomedical knowledge at your fingertips. Reliable predictions to anticipate risks. Interlinked data to find new targets and design novel drugs. Real-world evidence to evaluate success. These capabilities ...
-
by Genmab A/Sbased in DENMARK
Increasingly, data are transforming our understanding of diseases. This is especially true in cancer. We have invested in robust data science capabilities to enable rapid data-driven decision making as we advance our products through all stages of development. Integration of disparate data sets from clinical and pre-clinical studies is a ...
-
based in USA
KEGG, abbreviation of Kyoto Encyclopedia of Genes and Genomes, is a collection of databases, which is used for bioinformatics research, including data mining in genomics, proteomics, metabolomics and other omics studies, modeling and simulation in systems biology, and translational research in drug R & ...
-
Manufactured by CENTOGENE N.V.based in GERMANY
We work with partners to develop new disease models and new biomarkers of disease. We can also use our disease models to identify new drug targets and screen chemical compounds to identify potential new drug candidates. CENTOGENE provides companies with tools to accelerate drug discovery. From population screening studies that ...
-
based in UNITED KINGDOM
Autoimmune disease is caused by the breaking of self-tolerance. Oncimmune’s understanding of the immune system as a mediator of disease powers the ImmunoINSIGHTS service for autoimmune ...
-
based in USA
While healthcare data companies develop additional complex analytics technologies, personalized healthcare organizations are moving from ordinary analytics towards an area of predictive health insights to better understand current challenges and potential outcomes. Rather than just being presented information from previous events to an end user, healthcare predictive analytics approximate the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you